Campion Asset Management’s CVS Health CVS Stock Holding History

Campion Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,176	Closed	-$247K	–	94
2024 Q2	$247K	Sell	4,176 -1,732	-29%	-$108K	0.19%	84
2024 Q1	$471K	Sell	5,908 -712	-11%	-$54.4K	0.36%	57
2023 Q4	$523K	Sell	6,620 -315	-5%	-$22.4K	0.44%	48
2023 Q3	$484K	Sell	6,935 -15	-0.2%	-$1.06K	0.45%	49
2023 Q2	$480K	Buy	6,950 +455	+7%	+$32.4K	0.43%	52
2023 Q1	$483K	Buy	6,495 +775	+14%	+$65K	0.46%	50
2022 Q4	$533K	Sell	5,720 -400	-7%	-$38.6K	0.52%	47
2022 Q3	$584K	Hold	6,120	–	–	0.62%	36
2022 Q2	$567K	Hold	6,120	–	–	0.56%	40
2022 Q1	$619K	Hold	6,120	–	–	0.53%	40
2021 Q4	$631K	Hold	6,120	–	–	0.52%	39
2021 Q3	$519K	Buy	6,120 +145	+2%	+$12.1K	0.46%	43
2021 Q2	$499K	Sell	5,975 -1,330	-18%	-$109K	0.41%	47
2021 Q1	$550K	Buy	+7,305	New	+$532K	0.42%	45

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Campion Asset Management's CVS Position: Q3 2024 in Review

Campion Asset Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,176 shares — an estimated $247K sold.

Campion Asset Management first reported a position in CVS in Q1 2021 and held it in 14 quarters. The position peaked at $631K in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Campion Asset Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Campion Asset Management sold 4,176 CVS Health shares in Q3 2024, an estimated $247K.
Campion Asset Management first reported a position in CVS Health in Q1 2021 and held it in 14 quarters.
Campion Asset Management's CVS Health position peaked at $631K in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Campion Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.